周三盘中，生物科技公司莫德纳（Moderna, Inc.，股票代码：MRNA）股价大幅下挫，截至发稿时已下跌5.08%，引发市场关注。
据报道，美国特朗普政府计划结束对全球疫苗免疫联盟（GAVI）的支持。GAVI是一个国际疫苗援助组织，致力于改善发展中国家儿童获得新型和未充分使用的疫苗的机会。这一消息可能对疫苗制造商，尤其是莫德纳等主要参与者产生重大影响。
作为领先的mRNA疫苗技术公司，莫德纳的业务可能受到这一政策变动的直接影响。美国政府对GAVI支持的减少可能导致全球疫苗需求下降，特别是在发展中国家市场。这不仅可能影响莫德纳的收入预期，还可能对其在全球卫生领域的战略布局产生长期影响。投资者对这一潜在的市场变化反应强烈，导致莫德纳股价在当日交易中大幅下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.